$5.16
-0.03 (-0.58%)
Open$5.12
Previous Close$5.19
Day High$5.19
Day Low$5.08
52W High$8.75
52W Low$3.59
Volume—
Avg Volume215.6K
Market Cap377.38M
P/E Ratio—
EPS$-1.94
SectorPharmaceuticals
Analyst Ratings
Buy
10 analysts
Price Target
+291.9% upside
Current
$5.16
$5.16
Target
$20.22
$20.22
$15.45
$20.22 avg
$24.58
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 521.57M | 426.22M | 70.84M |
| Net Income | -198,089,686 | -145,689,889 | 13.06M |
| Profit Margin | -38.0% | -36.1% | 18.4% |
| EBITDA | -95,672,455 | -74,273,786 | 20.07M |
| Free Cash Flow | — | — | 11.95M |
| Rev Growth | +22.4% | +22.4% | +2.1% |
| Debt/Equity | 0.05 | 0.05 | 0.16 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,368.84 | +0.30% | 50.2 | 1.34T |
| JNJ | Johnson & Johnson | $274.87 | +0.94% | 41.3 | 665.03B |
| MRK | Merck & Co. Inc. | $147.01 | +0.05% | 117.2 | 371.99B |
| PFE | Pfizer Inc. | $29.30 | -1.94% | 40.0 | 173.27B |
| BMY | Bristol-Myers Squibb Co | $62.89 | -0.38% | 13.8 | 128.00B |
| ZTS | Zoetis Inc | $79.81 | -2.80% | 12.3 | 32.24B |